- Home
- CLDX vs JKS Comparison
CLDX vs JKS Comparison
Compare CLDX & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- JKS
- Stock Information
- Founded
- CLDX N/A
- JKS 2006
- Country
- CLDX United States
- JKS China
- Employees
- CLDX N/A
- JKS N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- JKS Semiconductors
- Sector
- CLDX Health Care
- JKS Technology
- Exchange
- CLDX Nasdaq
- JKS Nasdaq
- Market Cap
- CLDX 1.3B
- JKS N/A
- IPO Year
- CLDX 2008
- JKS 2010
- Fundamental
- Price
- CLDX $16.85
- JKS $18.20
- Analyst Decision
- CLDX Buy
- JKS Hold
- Analyst Count
- CLDX 8
- JKS 5
- Target Price
- CLDX $54.29
- JKS $27.19
- AVG Volume (30 Days)
- CLDX 767.1K
- JKS 865.3K
- Earning Date
- CLDX 05-05-2025
- JKS 03-26-2025
- Dividend Yield
- CLDX N/A
- JKS 15.99%
- EPS Growth
- CLDX N/A
- JKS N/A
- EPS
- CLDX N/A
- JKS N/A
- Revenue
- CLDX $7,020,000.00
- JKS $12,639,407,856.00
- Revenue This Year
- CLDX N/A
- JKS N/A
- Revenue Next Year
- CLDX $27.01
- JKS $17.25
- P/E Ratio
- CLDX N/A
- JKS $125.24
- Revenue Growth
- CLDX 1.99
- JKS N/A
- 52 Week Low
- CLDX $16.75
- JKS $16.70
- 52 Week High
- CLDX $47.00
- JKS $37.36
- Technical
- Relative Strength Index (RSI)
- CLDX 29.79
- JKS 30.80
- Support Level
- CLDX $19.48
- JKS $20.52
- Resistance Level
- CLDX $20.38
- JKS $23.21
- Average True Range (ATR)
- CLDX 1.03
- JKS 1.28
- MACD
- CLDX -0.17
- JKS -0.42
- Stochastic Oscillator
- CLDX 2.19
- JKS 5.94
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.